Stefano Meletti
Stefano Meletti, PhD is an expert in Neurology at Policlinico di Modena (Italy). As of October 2026, ScienceLeadR ranks Stefano Meletti in the top 1% of experts worldwide for Seizures and Epilepsy. Stefano Meletti has authored 344 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 1,051 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Public Health - Pharmacy - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 344
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest (SUPER-CAT Study). PMID 42837646 — mortality, hospital mortality, anesthetics, heart arrest, therapeutics, status epilepticus | Neurology | 2026 | 0 |
| Emergency treatment delay and underdosing are associated with poor outcome in non-convulsive status epilepticus. PMID 42501318 — epilepsy, mortality, emergencies, hospital mortality, therapeutics, emergency treatment, emergency service, hospital, status epilepticus | Epilepsia | 2026 | 0 |
| Statin use and risk of remote seizure after first new onset status epilepticus. PMID 42745495 — epilepsy, probability, seizures, hydroxymethylglutaryl-coa reductase inhibitors, status epilepticus | Epilepsia | 2026 | 0 |
| Status epilepticus in adults: From etiology to treatment response. PMID 42595744 — epilepsy, therapeutics, status epilepticus | Epilepsia | 2026 | 2 |
| Claustrum Involvement in New Onset Refractory Status Epilepticus: A Systematic Review. PMID 42552664 — epilepsy, mortality, neuroimaging, hospital mortality, claustrum, therapeutics, nervous system diseases, status epilepticus | Ann Clin Transl Neurol | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| COMparison Between Anakinra and Tocilizumab in NORSE COMBAT NORSE NCT07281027 — epilepsy, epileptic syndromes, recycling, receptors, interleukin-1, interleukin-1, interleukin 1 receptor antagonist protein, therapeutics, fires, infections, status epilepticus | Phase 3 | Not yet recruiting | 2026 |
| Home Ultra long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies NCT06855901 — anesthesia, epilepsy, safety, neuroimaging, epilepsies, partial, surgical procedures, operative, brain, neurosurgeons, electrodes, brain diseases, seizures, anesthesia, local, research, therapeutics, outpatients, prospective studies, surgeons | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map